Baotou Dongbao Bio-Tech Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Baotou Dongbao Biotechnology Co., Ltd. was established in 1997 (its predecessor, Baotou Fine Rubber Factory, was founded in 1960). It is a high-tech enterprise and a listed company on the Growth Enterprise Market. The company belongs to the biotechnology industry and is in line with the development direction of the national health industry plan. It is a strategic emerging industry encouraged by the country and also one of the seven emerging business formats listed by the Second Plenary Session of the 10th Central Committee of the Autonomous Region Party Committee. Our main products include "Jinlu" brand gelatin, "Yuansu" brand collagen, and "Baiyun" brand bone derived calcium hydrogen phosphate. The total assets of the company are nearly 1.7 billion yuan. In recent years, the company has been exploring and innovating, focusing on key elements of enterprise development, and achieved good operating results. The production and sales of its main products have also increased significantly. Dongbao Biotechnology currently has an annual production capacity of 13500 tons of gelatin and 4300 tons of collagen. In the future, it will launch extended products such as "artificial meat" and health nutrition supplements. The Ecological Science and Technology Park will create the "five firsts" in the Chinese gelatin industry, which are intelligent technology first, product quality first, production (operation) scale first, efficiency first, and production (work) environment first. It aims to build an Asian gelatin model factory and strive to become a global model factory. Dongbao Biotechnology attaches great importance to scientific development and has won honors such as the National Productivity Promotion Innovation Development Award, National Intellectual Property Advantage Enterprise, Autonomous Region Chairman's Quality Award (June 2016-June 2019), Excellent Private Enterprise in the Autonomous Region, Autonomous Region Scientific Development Enterprise, Baotou City's first batch of "century old stores", first batch of "technology giants", innovative enterprise, and specialized, refined, and new small and medium-sized enterprise. We have a demonstration base for entrepreneurship and innovation in the autonomous region, an autonomous region level enterprise technology center, a research and development center, and the Dongbao Biocollagen and Gelatin Bioengineering Application Research and Development Center of the Institute of Physics and Chemistry of the Chinese Academy of Sciences. Our joint laboratory with the Institute of Physics and Chemistry of the Chinese Academy of Sciences and other units has been recognized as one of the first batch of key laboratories for gelatin in China's light industry. The company's Biocollagen Green Manufacturing and Application Technology Research Enterprise Laboratory has been approved as a key laboratory in the autonomous region. The company continuously promotes technological progress, possesses multiple authorized invention patents, and has won the China Good Technology, Autonomous Region Science and Technology Achievement, and Municipal Science and Technology Progress Award. In recent years, it has established technical cooperation relationships with research institutions such as the University of California, Los Angeles. In 2015, Dongbao Biological Collagen Protein "Yuansu" Bovine Bone Collagen Peptide Powder was launched. This product was jointly developed by Dongbao Biological and the Institute of Physics and Chemistry of the Chinese Academy of Sciences, using grassland cow bone as raw material and using the Chinese invention patent (ZL200910241882. X) directed enzyme digestion technology to prepare, purify, and extract collagen protein. Rich in various amino acids required by the human body, maximizing the preservation of biological activity. It has small molecular weight, high purity, good water solubility, and is more easily absorbed by the human body. Since its launch, the product has been deeply recognized and praised by consumers due to its small molecule and easily absorbed technology and health concept. In the future, in addition to actively expanding its existing business, the company will also seize the opportunity of the "Healthy China" strategic development, increase the research and development efforts of cutting-edge technologies such as collagen active peptides that inhibit cancer cell proliferation, improve waste osteoporosis collagen, gelatin electrospinning biopharmaceutical materials, medical collagen hydrolysates (substitute for plasma gelatin), and seize the big health market with high-quality products and value-added services. We are currently implementing an additional stock issuance project and welcome domestic and foreign investors to participate in cooperation. We aim to coordinate and negotiate resource integration and strategic development to achieve a win-win situation. Dongbao Biotechnology, based on the production of modern collagen biological products, will continue to practice its corporate mission of "focusing on collagen, continuous innovation, and pursuing health". With the strong driving force of technological innovation and capital market, we will build a modern collagen biotechnology enterprise with stable development and sustained growth, making new efforts for China's biological industry and making positive contributions to human pursuit of health and beauty!. |
| Headquarter | Baotou City |
| Establish Date | 3/12/1997 |
| Listed Code | 300239.SZ |
| Listed Date | 7/6/2011 |
| Chairman | Wang Aiguo. |
| CEO | Liu Fang. |
| Website | www.dongbaoshengwu.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
